Research progress on gut microbiota in patients with gastric cancer, esophageal cancer, and small intestine cancer
- PMID: 34037843
- DOI: 10.1007/s00253-021-11358-z
Research progress on gut microbiota in patients with gastric cancer, esophageal cancer, and small intestine cancer
Abstract
The pathogenesis of gut microbiota in humans can be indicated due to the wide application of techniques, such as 16S rRNA sequencing. Presently, several studies have found a significant difference in fecal flora between normal individuals and patients with gastric cancer. Although clinical research on the feedback mechanism of gastric flora and gut microbiota is lacking, clarifying the relationship between gut microbiota and the characteristics of cancer is significant for the early diagnosis of gastric cancer. This study was conducted to review the results of several studies in the past 5 years and analyze the intestinal bacteria in patients with gastric cancer and compare them with those in patients with esophageal and small intestine cancers. It was found that the gut microbiota in patients with gastric cancer was similar to that in patients with esophageal cancer. However, making an analysis and comparing the gut microbiota in patients with small intestine and gastric cancers was impossible due to the low incidence of small intestinal cancer. Our review summarized the research progress on using the gut microbiota for early screening for gastric cancer, and the results of this study will provide a further direction in this field. KEY POINTS: • We reviewed several relative mechanisms of the gut microbiota related to gastric cancer. • The gut microbiota in gastric, esophageal, and small intestine cancers are significantly different in types and quantity, and we have provided some tips for further research. • A prospective review of sequencing methods and study results on the gut microbiota in gastric, esophageal, and small intestine cancers was described.
Keywords: 16S rRNA; Esophageal cancer; Gastric cancer; Gut microbiota; Small intestine cancer.
References
-
- Allocati N, Masulli M, Alexeyev M, Di Ilio C (2013) Escherichia coli in Europe: an overview. Int J Environ Res Public Health 10:6235–6254. https://doi.org/10.3390/ijerph10126235 - DOI - PubMed - PMC
-
- Amieva M, Peek RM (2016) Pathobiology of Helicobacter pylori–induced gastric cancer. Gastroenterology 150:64–78. https://doi.org/10.1053/j.gastro.2015.09.004 - DOI - PubMed
-
- Arthur JC, Perez-Chanona E, Mühlbauer M, Tomkovich S, Uronis JM, Fan T-J, Campbell BJ, Abujamel T, Dogan B, Rogers AB, Rhodes JM, Stintzi A, Simpson KW, Hansen JJ, Keku TO, Fodor AA, Jobin C (2012) Intestinal inflammation targets cancer-inducing activity of the microbiota. Science 338:120–123. https://doi.org/10.1126/science.1224820 - DOI - PubMed - PMC
-
- Ashida H, Ogawa M, Mimuro H, Sasakawa C (2009) Shigella infection of intestinal epithelium and circumvention of the host innate defense system. Curr Top Microbiol Immunol 337:231–255. https://doi.org/10.1007/978-3-642-01846-6_8
-
- Bagga D, Reichert JL, Koschutnig K, Aigner CS, Holzer P, Koskinen K, Moissl-Eichinger C, Schöpf V (2018) Probiotics drive gut microbiome triggering emotional brain signatures. Gut Microbes 9:486-496. https://doi.org/10.1080/19490976.2018.1460015
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
